NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects United States Remove constraint Subjects: United States Languages English Remove constraint Languages: English Copyright Public domain Remove constraint Copyright: Public domain Publication Year 2000 to 2021 Remove constraint Publication Year: <span class="from" data-blrl-begin="2000">2000</span> to <span class="to" data-blrl-end="2021">2021</span>

Search Results

4. 30-Day notices, 135-day premarket approval (PMA) supplements and 75-day humanitarian device exemption (HDE) supplements for manufacturing method or process changes: guidance for industry and Food and Drug Administration staff

7. ACF cannot ensure that all child victims of abuse and neglect have court representation

8. ACOs' strategies for transitioning to value-based care: lessons from the Medicare shared savings program

12. Accelerating adoption of assistive technology to reduce physical strain among family caregivers of the chronically disabled elderly living at home

14. Access and use of electronic health information by individuals with cancer: 2017-2018

16. The Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program: guidance for industry, accreditation bodies, testing laboratories, and Food and Drug Administration staff

17. Acne vulgaris: establishing effectiveness of drugs intended for treatment

18. Adaptive designs for clinical trials of drugs and biologics

19. Addressing teen pregnancy risks for youth living in out-of-home care: implementing POWER through choices 2010 : implementation report

20. Administrative procedures for CLIA categorization: guidance for industry and Food and Drug Administration staff

21. Adolescent and young adult substance use: federal grants for prevention, treatment, and recovery services and for research : report to Congressional committees

22. Advance care planning among Medicare fee-for-service beneficiaries and practitioners: final report

23. Advancement of emerging technology applications for pharmaceutical innovation and modernization

25. Adverse events in long-term-care hospitals: national incidence among Medicare beneficiaries

26. The Affordable Care Act and African Americans

27. The Affordable Care Act and Asian Americans and Pacific Islanders

28. The Affordable Care Act and Latinos

29. The Affordable Care Act and adolescents

30. The Affordable Care Act and women

31. Affordable Care Act has led to historic, widespread increase in health insurance coverage

32. Affordable Care Act: IRS should mitigate limitations of data to be used for the age and gender adjustment for the tax on high-cost health plans : report to Congressional committees

33. The Affordable Care Act: advancing the health of women and children

35. The aging services network: accomplishments and challenges in serving a growing elderly population

36. Air ambulance: data collection and transparency needed to enhance DOT oversight : report to the Committee on Transportation and Infrastructure, House of Representatives

37. Air travel and communicable diseases: status of research efforts and action still needed to develop federal preparedness plan : testimony before the Subcommittee on Space and Aeronautics, Committee on Science, Space, and Technology, House of Representatives

39. Allergic rhinitis: developing drug products for treatment

42. Amyotrophic lateral sclerosis: developing drugs for treatment

43. Analysis of 2017 premium changes and insurer participation in the Affordable Care Act's health insurance marketplaces

44. An analysis of private-sector prices for hospital admissions

46. Analysis of supply, distribution, demand, and access issues associated with immune globulin intravenous (IGIV): final report

49. Anthrax: developing drugs for prophylaxis of inhalational anthrax

50. Antibacterial therapies for patients with an unmet medical need for the treatment of serious bacterial diseases